ReNeuron Receives Notice Of Allowance From US Patent Office For Neural Stem Cell Transplantation Patent Application.

January 24, 2006 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

ReNeuron Group plc (LSE: RENE.L) today announced that it has received a Notice of Allowance from the US Patent and Trademark Office concerning a key patent application for methods of transplantation of neural stem cells.

Twitter
LinkedIn
Facebook
Email
Print

Europe